Muhammad Furqan

This study shows that Kindlin-1 loss in cutaneous squamous cell carcinoma disrupts ECM-vascular organization, leading to hypoxia and tumor progression.

This study screens a large compound library across patient-derived GBM stem cells to identify effective drugs targeting tumor heterogeneity and presents validated hits for further exploration.

This study identifies three compounds targeting glioblastoma stem cells using machine learning and high-throughput screening of patient-derived models.

This study shows that systemic FAK inhibition reduces immunosuppressive macrophages in glioblastoma by blocking monocyte trafficking, enhancing T cell activity and improving survival in a mouse model.

This study identifies a synergistic combination of FAK and MEK inhibitors that effectively targets glioblastoma heterogeneity and improves therapeutic outcomes.